Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

ADAM17-deficiency on microglia but not on macrophages promotes phagocytosis and functional recovery after spinal cord injury.

Sommer D, Corstjens I, Sanchez S, Dooley D, Lemmens S, Van Broeckhoven J, Bogie J, Vanmierlo T, Vidal PM, Rose-John S, Gou-Fabregas M, Hendrix S.

Brain Behav Immun. 2019 Mar 6. pii: S0889-1591(18)31201-7. doi: 10.1016/j.bbi.2019.02.032. [Epub ahead of print]

2.

Endogenous Interleukin-10 Deficiency Exacerbates Vascular Pathology in Traumatic Cervical Spinal Cord Injury.

Badner A, Vidal PM, Hong J, Hacker J, Fehlings MG.

J Neurotrauma. 2019 Apr 24. doi: 10.1089/neu.2018.6081. [Epub ahead of print]

PMID:
30843463
3.

Targeting the Dopaminergic System in Autoimmunity.

Vidal PM, Pacheco R.

J Neuroimmune Pharmacol. 2019 Jan 19. doi: 10.1007/s11481-019-09834-5. [Epub ahead of print] Review.

PMID:
30661214
4.

Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system.

Vidal PM, Ulndreaj A, Badner A, Hong J, Fehlings MG.

J Neuroinflammation. 2018 Aug 6;15(1):222. doi: 10.1186/s12974-018-1257-7.

5.

Delayed decompression exacerbates ischemia-reperfusion injury in cervical compressive myelopathy.

Vidal PM, Karadimas SK, Ulndreaj A, Laliberte AM, Tetreault L, Forner S, Wang J, Foltz WD, Fehlings MG.

JCI Insight. 2017 Jun 2;2(11). pii: 92512. doi: 10.1172/jci.insight.92512. eCollection 2017 Jun 2.

6.

Personality, Cortisol, and Cognition in Non-demented Elderly Subjects: Results from a Population-Based Study.

Ouanes S, Castelao E, von Gunten A, Vidal PM, Preisig M, Popp J.

Front Aging Neurosci. 2017 Mar 14;9:63. doi: 10.3389/fnagi.2017.00063. eCollection 2017.

7.

Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6.

Vangansewinkel T, Geurts N, Quanten K, Nelissen S, Lemmens S, Geboes L, Dooley D, Vidal PM, Pejler G, Hendrix S.

FASEB J. 2016 May;30(5):2040-57. doi: 10.1096/fj.201500114R. Epub 2016 Feb 25.

PMID:
26917739
8.

The Complement Receptor C5aR Has a Dual, Time-Dependent Effect on the Outcome of Spinal Cord Injury.

Ulndreaj A, Marbourg JM, Vidal PM.

J Neurosci. 2015 Sep 9;35(36):12325-7. doi: 10.1523/JNEUROSCI.2380-15.2015. No abstract available.

9.

Oncostatin M reduces lesion size and promotes functional recovery and neurite outgrowth after spinal cord injury.

Slaets H, Nelissen S, Janssens K, Vidal PM, Lemmens E, Stinissen P, Hendrix S, Hellings N.

Mol Neurobiol. 2014 Dec;50(3):1142-51. doi: 10.1007/s12035-014-8795-5. Epub 2014 Jul 5.

PMID:
24996996
10.

Glycine receptors control the generation of projection neurons in the developing cerebral cortex.

Avila A, Vidal PM, Tielens S, Morelli G, Laguesse S, Harvey RJ, Rigo JM, Nguyen L.

Cell Death Differ. 2014 Nov;21(11):1696-708. doi: 10.1038/cdd.2014.75. Epub 2014 Jun 13.

11.

ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in mice.

Vidal PM, Lemmens E, Avila A, Vangansewinkel T, Chalaris A, Rose-John S, Hendrix S.

Cell Death Dis. 2013 Dec 12;4:e954. doi: 10.1038/cddis.2013.466.

12.

Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4.

Nelissen S, Vangansewinkel T, Geurts N, Geboes L, Lemmens E, Vidal PM, Lemmens S, Willems L, Boato F, Dooley D, Pehl D, Pejler G, Maurer M, Metz M, Hendrix S.

Neurobiol Dis. 2014 Feb;62:260-72. doi: 10.1016/j.nbd.2013.09.012. Epub 2013 Sep 26.

13.

Glycine receptor α2 subunit activation promotes cortical interneuron migration.

Avila A, Vidal PM, Dear TN, Harvey RJ, Rigo JM, Nguyen L.

Cell Rep. 2013 Aug 29;4(4):738-50. doi: 10.1016/j.celrep.2013.07.016. Epub 2013 Aug 15.

14.

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment.

Rietveld CA, Medland SE, Derringer J, Yang J, Esko T, Martin NW, Westra HJ, Shakhbazov K, Abdellaoui A, Agrawal A, Albrecht E, Alizadeh BZ, Amin N, Barnard J, Baumeister SE, Benke KS, Bielak LF, Boatman JA, Boyle PA, Davies G, de Leeuw C, Eklund N, Evans DS, Ferhmann R, Fischer K, Gieger C, Gjessing HK, Hägg S, Harris JR, Hayward C, Holzapfel C, Ibrahim-Verbaas CA, Ingelsson E, Jacobsson B, Joshi PK, Jugessur A, Kaakinen M, Kanoni S, Karjalainen J, Kolcic I, Kristiansson K, Kutalik Z, Lahti J, Lee SH, Lin P, Lind PA, Liu Y, Lohman K, Loitfelder M, McMahon G, Vidal PM, Meirelles O, Milani L, Myhre R, Nuotio ML, Oldmeadow CJ, Petrovic KE, Peyrot WJ, Polasek O, Quaye L, Reinmaa E, Rice JP, Rizzi TS, Schmidt H, Schmidt R, Smith AV, Smith JA, Tanaka T, Terracciano A, van der Loos MJ, Vitart V, Völzke H, Wellmann J, Yu L, Zhao W, Allik J, Attia JR, Bandinelli S, Bastardot F, Beauchamp J, Bennett DA, Berger K, Bierut LJ, Boomsma DI, Bültmann U, Campbell H, Chabris CF, Cherkas L, Chung MK, Cucca F, de Andrade M, De Jager PL, De Neve JE, Deary IJ, Dedoussis GV, Deloukas P, Dimitriou M, Eiríksdóttir G, Elderson MF, Eriksson JG, Evans DM, Faul JD, Ferrucci L, Garcia ME, Grönberg H, Guðnason V, Hall P, Harris JM, Harris TB, Hastie ND, Heath AC, Hernandez DG, Hoffmann W, Hofman A, Holle R, Holliday EG, Hottenga JJ, Iacono WG, Illig T, Järvelin MR, Kähönen M, Kaprio J, Kirkpatrick RM, Kowgier M, Latvala A, Launer LJ, Lawlor DA, Lehtimäki T, Li J, Lichtenstein P, Lichtner P, Liewald DC, Madden PA, Magnusson PK, Mäkinen TE, Masala M, McGue M, Metspalu A, Mielck A, Miller MB, Montgomery GW, Mukherjee S, Nyholt DR, Oostra BA, Palmer LJ, Palotie A, Penninx BW, Perola M, Peyser PA, Preisig M, Räikkönen K, Raitakari OT, Realo A, Ring SM, Ripatti S, Rivadeneira F, Rudan I, Rustichini A, Salomaa V, Sarin AP, Schlessinger D, Scott RJ, Snieder H, St Pourcain B, Starr JM, Sul JH, Surakka I, Svento R, Teumer A; LifeLines Cohort Study, Tiemeier H, van Rooij FJ, Van Wagoner DR, Vartiainen E, Viikari J, Vollenweider P, Vonk JM, Waeber G, Weir DR, Wichmann HE, Widen E, Willemsen G, Wilson JF, Wright AF, Conley D, Davey-Smith G, Franke L, Groenen PJ, Hofman A, Johannesson M, Kardia SL, Krueger RF, Laibson D, Martin NG, Meyer MN, Posthuma D, Thurik AR, Timpson NJ, Uitterlinden AG, van Duijn CM, Visscher PM, Benjamin DJ, Cesarini D, Koellinger PD.

Science. 2013 Jun 21;340(6139):1467-71. doi: 10.1126/science.1235488. Epub 2013 May 30.

15.

The role of "anti-inflammatory" cytokines in axon regeneration.

Vidal PM, Lemmens E, Dooley D, Hendrix S.

Cytokine Growth Factor Rev. 2013 Feb;24(1):1-12. doi: 10.1016/j.cytogfr.2012.08.008. Epub 2012 Sep 15. Review.

PMID:
22985997
16.

Late blocking of peripheral TNF-α is ineffective after spinal cord injury in mice.

Vidal PM, Lemmens E, Geboes L, Vangansewinkel T, Nelissen S, Hendrix S.

Immunobiology. 2013 Feb;218(2):281-4. doi: 10.1016/j.imbio.2012.05.007. Epub 2012 May 23.

PMID:
22749984
17.

[CoLaus: diabetes and dyslipidemia, there is always something new!].

Vollenweider P, Vaucher J, Bastardot F, Schmid R, Vidal PM, Waeber G.

Rev Med Suisse. 2011 Nov 2;7(315):2122, 2124-6. French.

PMID:
22187780
18.

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.

Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, Holm H, Sanna S, Kavousi M, Baumeister SE, Coin LJ, Deng G, Gieger C, Heard-Costa NL, Hottenga JJ, Kühnel B, Kumar V, Lagou V, Liang L, Luan J, Vidal PM, Mateo Leach I, O'Reilly PF, Peden JF, Rahmioglu N, Soininen P, Speliotes EK, Yuan X, Thorleifsson G, Alizadeh BZ, Atwood LD, Borecki IB, Brown MJ, Charoen P, Cucca F, Das D, de Geus EJ, Dixon AL, Döring A, Ehret G, Eyjolfsson GI, Farrall M, Forouhi NG, Friedrich N, Goessling W, Gudbjartsson DF, Harris TB, Hartikainen AL, Heath S, Hirschfield GM, Hofman A, Homuth G, Hyppönen E, Janssen HL, Johnson T, Kangas AJ, Kema IP, Kühn JP, Lai S, Lathrop M, Lerch MM, Li Y, Liang TJ, Lin JP, Loos RJ, Martin NG, Moffatt MF, Montgomery GW, Munroe PB, Musunuru K, Nakamura Y, O'Donnell CJ, Olafsson I, Penninx BW, Pouta A, Prins BP, Prokopenko I, Puls R, Ruokonen A, Savolainen MJ, Schlessinger D, Schouten JN, Seedorf U, Sen-Chowdhry S, Siminovitch KA, Smit JH, Spector TD, Tan W, Teslovich TM, Tukiainen T, Uitterlinden AG, Van der Klauw MM, Vasan RS, Wallace C, Wallaschofski H, Wichmann HE, Willemsen G, Würtz P, Xu C, Yerges-Armstrong LM; Alcohol Genome-wide Association (AlcGen) Consortium; Diabetes Genetics Replication and Meta-analyses (DIAGRAM+) Study; Genetic Investigation of Anthropometric Traits (GIANT) Consortium; Global Lipids Genetics Consortium; Genetics of Liver Disease (GOLD) Consortium; International Consortium for Blood Pressure (ICBP-GWAS); Meta-analyses of Glucose and Insulin-Related Traits Consortium (MAGIC), Abecasis GR, Ahmadi KR, Boomsma DI, Caulfield M, Cookson WO, van Duijn CM, Froguel P, Matsuda K, McCarthy MI, Meisinger C, Mooser V, Pietiläinen KH, Schumann G, Snieder H, Sternberg MJ, Stolk RP, Thomas HC, Thorsteinsdottir U, Uda M, Waeber G, Wareham NJ, Waterworth DM, Watkins H, Whitfield JB, Witteman JC, Wolffenbuttel BH, Fox CS, Ala-Korpela M, Stefansson K, Vollenweider P, Völzke H, Schadt EE, Scott J, Järvelin MR, Elliott P, Kooner JS.

Nat Genet. 2011 Oct 16;43(11):1131-8. doi: 10.1038/ng.970.

19.

Psychiatric co-morbidities and cardiovascular risk factors in people with lifetime history of epilepsy of an urban community.

Novy J, Castelao E, Preisig M, Vidal PM, Waeber G, Vollenweider P, Rossetti AO.

Clin Neurol Neurosurg. 2012 Jan;114(1):26-30. doi: 10.1016/j.clineuro.2011.08.019. Epub 2011 Sep 28.

PMID:
21955581
20.

Cardiologists' educational needs for preventive cardiology in Europe.

Tokgozoglu L, Vidal PM, Vanuzzo D.

Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):743-4. doi: 10.1177/1741826711415721. No abstract available.

PMID:
21945919
21.

Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.

Vidal PM, Trindade PA, Garcia TO, Pacheco RL, Costa SF, Reinert C, Hiramatsu K, Mamizuka EM, Garcia CP, Levin AS.

Infect Control Hosp Epidemiol. 2009 Feb;30(2):139-45. doi: 10.1086/593954.

PMID:
19146463
22.

The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome.

Firmann M, Mayor V, Vidal PM, Bochud M, Pécoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, Danoff TM, Stirnadel HA, Waterworth D, Mooser V, Waeber G, Vollenweider P.

BMC Cardiovasc Disord. 2008 Mar 17;8:6. doi: 10.1186/1471-2261-8-6.

23.

The D1822V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons.

Guerreiro CS, Cravo ML, Brito M, Vidal PM, Fidalgo PO, Leitão CN.

Am J Clin Nutr. 2007 Jun;85(6):1592-7.

PMID:
17556698
24.

Simultaneous occurrence of pulmonary tuberculosis and carcinomatous lymphangitis.

Tuon FF, Miyaji KT, de Vidal PM, da Silva LF, Kono A, Franca FO.

Rev Soc Bras Med Trop. 2007 Jan-Feb;40(1):76-7.

25.

Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy.

Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME.

J Clin Oncol. 2005 Mar 1;23(7):1431-8. Epub 2005 Jan 31.

PMID:
15684319
26.

Nutritional risk and status assessment in surgical patients: a challenge amidst plenty.

Mourão F, Amado D, Ravasco P, Vidal PM, Camilo ME.

Nutr Hosp. 2004 Mar-Apr;19(2):83-8.

PMID:
15049409
27.

Cancer: disease and nutrition are key determinants of patients' quality of life.

Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME.

Support Care Cancer. 2004 Apr;12(4):246-52. Epub 2004 Mar 3.

PMID:
14997369
28.

Nutritional deterioration in cancer: the role of disease and diet.

Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME.

Clin Oncol (R Coll Radiol). 2003 Dec;15(8):443-50.

PMID:
14689999
29.

Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.

Kong XB, Zhu QY, Vidal PM, Watanabe KA, Polsky B, Armstrong D, Ostrander M, Lang SA Jr, Muchmore E, Chou TC.

Antimicrob Agents Chemother. 1992 Apr;36(4):808-18.

30.
31.

Toxicity, elimination, and metabolism of 10-ethyl-10-deazaaminopterin in rats and dogs.

Fanucchi MP, Kinahan JJ, Samuels LL, Hancock C, Chou TC, Niedzwiecki D, Farag F, Vidal PM, DeGraw JI, Sternberg SS, et al.

Cancer Res. 1987 May 1;47(9):2334-9.

32.

Fluorometric high-performance liquid chromatographic analysis of 10-deazaaminopterin, 10-ethyl-10-deazaaminopterin, and known metabolites.

Kinahan JJ, Samuels LL, Farag F, Fanucchi MP, Vidal PM, Sirotnak FM, Young CW.

Anal Biochem. 1985 Oct;150(1):203-13.

PMID:
2417507
33.

Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections.

Feinberg A, Leyland-Jones B, Fanucchi MP, Hancock C, Fox JJ, Watanabe KA, Vidal PM, Williams L, Young CW, Philips FS.

Antimicrob Agents Chemother. 1985 May;27(5):733-8.

34.

Structures of metabolites isolated from urine of mice treated with the antiviral agent, 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-methyluracil.

Feinberg A, Vidal PM, Fox JJ, Watanabe KA, Chun MW, Field FH, Bencsath A, Chait B, Philips FS.

Drug Metab Dispos. 1984 Nov-Dec;12(6):784-6. No abstract available.

PMID:
6150831
35.

Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine.

Philips FS, Feinberg A, Chou TC, Vidal PM, Su TL, Watanabe KA, Fox JJ.

Cancer Res. 1983 Aug;43(8):3619-27. No abstract available.

36.

Physiologic disposition and intracellular localization of isometamidium.

Philips FS, Sternberg SS, Cronin AP, Sodergren JE, Vidal PM.

Cancer Res. 1967 Feb;27(2):333-49. No abstract available.

37.

Hydroxyurea. I. Acute cell death in proliferating tissues in rats.

Philips FS, Sternberg SS, Schwartz HS, Cronin AP, Sodergren JE, Vidal PM.

Cancer Res. 1967 Jan;27(1):61-75. No abstract available.

38.

Toxicity and physiologic disposition of 2-amino-4',4"-bis(5-methyl-2-imidazolin-2-yl)terephthalanilide (NSC-66761).

Philips FS, Sternberg SS, Cronin AP, Vidal PM.

Cancer Chemother Rep. 1966 Jan-Feb;50(1):9-23. No abstract available.

PMID:
4956044
39.

TOXICOLOGICAL STUDIES OF CALVACIN.

STERNBERG SS, PHILIPS FS, CRONIN AP, SODERGREN JE, VIDAL PM.

Cancer Res. 1963 Aug;23:1036-44. No abstract available.

40.

Cyclophosphamide and urinary bladder toxicity.

PHILIPS FS, STERNBERG SS, CRONIN AP, VIDAL PM.

Cancer Res. 1961 Dec;21:1577-89. No abstract available.

PMID:
14486208

Supplemental Content

Loading ...
Support Center